新型夹层专用混合支架移植物用于DeBakey I型主动脉夹层患者
单中心回顾性分析2016年9月至2021年2月109例非急性DeBakey I型主动脉夹层行冰冻象鼻术患者,比较软远端夹层专用支架移植物(S组41例)与硬质Z形(Z组46例)、环状(R组22例)支架移植物。S组远端支架诱发新破口豁免率100%,Z组68.9%、R组92.9%(log-rank=0.14),无显著差异;S组4年生存率95.06%,Z组80.44%、R组71.59%。多变量分析显示结缔组织病(HR=5.62,P=0.11)和支架直径(HR=1.37,P=0.034)是远端支架诱发新破口的强预测因素。
要点
- 软远端夹层专用支架移植物组远端支架诱发新破口豁免率100%,Z组68.9%、R组92.9%(log-rank=0.14)。
- 4年生存率S组95.06%,Z组80.44%,R组71.59%。
- 支架直径是远端支架诱发新破口的预测因素(HR=1.37,P=0.034)。
核心结论
- 软远端夹层专用混合支架移植物对非急性DeBakey I型主动脉夹层有效,与硬质远端支架相比可减少远端并发症发生率。
- 需长期结局来确定新移植物的潜在优缺点。
研究设计与样本
- 单中心回顾性研究,纳入2016年9月至2021年2月非急性DeBakey I型主动脉夹层行冰冻象鼻术患者109例。
- 按所用支架移植物类型分3组:Z组46例(42.2%)使用硬质远端Z形镍钛合金支架移植物(E-Vita,Medtronic);R组22例(20.2%)使用硬质环状镍钛合金支架移植物(Thoraflex);S组41例(37.6%)使用软远端夹层专用支架移植物。
- 分析远端支架诱发新破口的预测因素,终点为住院和中期随访结果。
主要发现
- 早期结果无显著差异。
- 远端支架诱发新破口豁免率Z组68.9% vs R组92.9% vs S组100%(log-rank=0.14)。
- 随访期间组间无显著差异。
- 4年生存率Z组80.44%、R组71.59%、S组95.06%。
- 多变量分析显示结缔组织病(HR=5.62,P=0.11)和支架直径(HR=1.37,P=0.034)是远端支架诱发新破口的强预测因素。
局限性
- 原文未报告局限性;但作者在结论中指出需长期结局来确定新移植物的潜在优缺点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We present our first experience of using a new dissection-specific hybrid stent graft (SG) (the 'Soft Elephant Trunk') in the frozen elephant trunk technique, in patients with non-acute DeBakey type I aortic dissection. METHODS: Between September 2016 and February 2021, patients with non-acute DeBakey type I aortic dissection underwent the frozen elephant trunk procedure at our centre using 3 SG types: group Z used stiff, distal Z-shaped nitinol SGs (E-Vita, Medtronic); group R used a stiff, ring-shaped nitinol SG (Thoraflex); and group S used a soft, distal dissection-specific SG. Predictors of distal SG-induced new entry were analysed. End points were hospital- and midterm-follow-up results. RESULTS: The study comprised 109 patients with 46 (42.2%), 22 (20.2%) and 41 (37.6%) patients in groups Z, R and S, respectively. No significant differences were found in early outcomes. Freedom from distal SG-induced new entry was comparable in groups Z, R and S (68.9% vs 92.9% vs 100%, log-rank = 0.14). There was no significant difference in follow-up between the groups. Four-year survival rates were 80.44%, 71.59% and 95.06% in groups Z, R and S, respectively. On multivariable analysis, the presence of connective tissue disorders [hazard ratio (HR) = 5.62, P = 0.11] and SG diameter (HR = 1.37, P = 0.034) were strong predictors of distal SG-induced new entry. CONCLUSIONS: Dissection-specific hybrid SG with a soft distal end is effective in patients with non-acute DeBakey type I aortic dissection. Compared to non-soft distal SGs, this can reduce the incidence of distal complications. Long-term outcomes are necessary to determine the potential advantages and disadvantages of the new prosthesis.
引用
- Charchyan E, Breshenkov D, Belov Y, et al. A new dissection-specific hybrid stent graft for patients with DeBakey type I aortic dissection. Eur J Cardiothorac Surg. 2022. PMID: 34734250. doi:10.1093/ejcts/ezab441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。